To provide a broader view of the role of CD47 in the interplay of the tumor-immune system, we compared the proportions of CD47+ tumor cells and CD47+ TIICs in each histological subtype, and also in the central and peripheral tissue compartment. This evidence concerns the gene CD47 and neoplasm.